AbbVie

AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, and YouTube.

We are AbbVie. A global Fortune 500 biopharmaceutical company creating life-changing medicines and first-in-kind solutions that make a real difference in people’s lives.

Our 50,000+ employees across geographies, disciplines, and therapeutic areas put impact at the core of every decision. With over $50B invested in R&D since our founding in 2013, we’re always focused on helping people and communities thrive for generations to come.

1 North Waukegan Road
North Chicago, IL 60064

Tel: 1-800-255-5162

Visit website

Email Us

Stock Symbol: ABBV
Stock Exchange: NYSE

NEWS

Credit: CDC Public Health Image Library (PHIL) #23

Policy

Mobilizing Drug Development Efforts Against the Novel Coronavirus

Now that global responses are fully mobilized, what is being done to identify and develop drugs and vaccines against this novel coronavirus?

February 14, 2020

15 min read

Chelsea Weidman Burke

Business

Biotech Q4 Earnings Synopsis: Major Restructuring and Overall Growth Are Themes

It was a busy week for biotech quarterly and annual reports. Here’s a look at some of the top stories including Bristol-Myers Squibb, AbbVie, GSK, Merck and more.

February 7, 2020

6 min read

Mark Terry

Pharm Country

China Coronavirus Update: Continued Spread, Run on Antivirals and Facemasks, Baby Diagnosed

The most recent figure for the China coronavirus outbreak is 28,018 confirmed cases with 563 deaths in China. Chinese health authorities indicate 19 foreigners have been infected by the virus. There are reports that a Chinese newborn is the youngest person to become infected. The infant was diagnosed 30 hours after birth, apparently having gotten it from the mother.

February 6, 2020

4 min read

Mark Terry

BioMidwest

AbbVie’s HIV Drug Aluvia Seen as Potential Treatment for Coronavirus

The Chinese government is turning to a drug developed by AbbVie for HIV patients as a potential treatment for the outbreak.

January 27, 2020

2 min read

Alex Keown

Deals

Allergan and AbbVie Sell Assets, Inching Closer to Completing Merger

As AbbVie and Allergan near completion of the $63 billion merger, the two companies are shedding some assets in order to meet demands of regulators over concerns of a monopoly.

January 27, 2020

3 min read

Alex Keown

Job Trends

Clinical Catch-Up: January 13-17

There were plenty of clinical trial announcements this week. Here’s a look.

January 17, 2020

7 min read

Mark Terry

Drug Development

AbbVie’s Skyrizi Beats Out Novartis’ Cosentyx in Plaque Psoriasis

AbbVie reported that its Skyrizi met both primary and all ranked secondary endpoints in its Phase III trial that went head-to-head with Novartis’ Cosentyx in plaque psoriasis.

January 14, 2020

3 min read

Mark Terry

Deals

M&A for 2019 was Big; Will 2020 Be Even Bigger?

Consulting firm EY released its annual report on mergers and acquisitions (M&A) to coincide with the JP Morgan Healthcare conference this week. For 2019, EY indicates there were $357 billion in life science deals, an “all-time record,” surpassing the previous high in 2014.

January 13, 2020

4 min read

Mark Terry

Business

AbbVie Sets up Allergan Aesthetics Ahead of Finalizing its $63 Billion Acquisition

While Allergan and AbbVie prepare to complete their $63 billion merger later this year, plans are being laid out for a new, stand-alone company called Allergan Aesthetics that will include Botox as a tent pole.

January 9, 2020

3 min read

Alex Keown

JOBS